Relay Therapeutics Inc (RLAY) with a beta value of 1.59 appears to be a promising investment opportunity.
Relay Therapeutics Inc (NASDAQ: RLAY) on Friday, plunged -1.46% from the previous trading day, before settling in for the closing price of $4.78. Within the